Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver Fulltext Access 11 Pages 2010
Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions Fulltext Access 11 Pages 2010
Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness Fulltext Access 11 Pages 2010
Characterization and engraftment of long-term serum-free human fetal liver cell cultures Fulltext Access 11 Pages 2010
Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy Fulltext Access 11 Pages 2010
Animal serum-free expansion and differentiation of human mesenchymal stromal cells Fulltext Access 11 Pages 2010
Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes Fulltext Access 11 Pages 2010
Establishment of immortalized mesenchymal stromal cells with red fluorescence protein expression for in vivo transplantation and tracing in the rat model with traumatic brain injury Fulltext Access 11 Pages 2010
Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood Fulltext Access 11 Pages 2010
Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells Fulltext Access 11 Pages 2010
Growth factor and cytokine expression of human mesenchymal stromal cells is not altered in an in vitro model of tissue damage Fulltext Access 11 Pages 2010
Dual contrast magnetic resonance imaging tracking of iron-labeled cells in vivo Fulltext Access 11 Pages 2010
Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment Fulltext Access 11 Pages 2010
Surgically Unresectable Regional Melanoma Metastases in a Patient With Renal Failure and Peripheral Vascular Disease: Are There Safe and Potentially Effective Treatments? Fulltext Access 11 Pages 2010
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1 Fulltext Access 11 Pages 2010
Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation Fulltext Access 11 Pages 2010
PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60 Fulltext Access 11 Pages 2010
Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies Fulltext Access 11 Pages 2010
Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells Fulltext Access 11 Pages 2010
Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia Fulltext Access 11 Pages 2010
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation Fulltext Access 11 Pages 2010
Role of PI3K on the regulation of BMP2-induced β-Catenin activation in human bone marrow stem cells Fulltext Access 11 Pages 2010
On the effect of X-ray irradiation on the deformation and fracture behavior of human cortical bone Fulltext Access 11 Pages 2010
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo Fulltext Access 11 Pages 2010
Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells Fulltext Access 11 Pages 2010
Apatite content of collagen materials dose-dependently increases pre-osteoblastic cell deposition of a cement line-like matrix Fulltext Access 11 Pages 2010
A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites Fulltext Access 11 Pages 2010
Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials Fulltext Access 11 Pages 2010
Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells Fulltext Access 11 Pages 2010
Ultrasound-induced activation of Wnt signaling in human MG-63 osteoblastic cells Fulltext Access 11 Pages 2010
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass Fulltext Access 11 Pages 2010
Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data Fulltext Access 11 Pages 2010
Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise Fulltext Access 11 Pages 2010
Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations Fulltext Access 11 Pages 2010
Do drastic weather effects on diet influence changes in chemical composition, mechanical properties and structure in deer antlers? Fulltext Access 11 Pages 2010
Reference intervals of biochemical bone turnover markers for Saudi Arabian women: A cross-sectional study Fulltext Access 11 Pages 2010
Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells Fulltext Access 11 Pages 2010
Identification of cells at early and late stages of polarization during odontoblast differentiation using pOBCol3.6GFP and pOBCol2.3GFP transgenic mice Fulltext Access 11 Pages 2010
Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia Fulltext Access 11 Pages 2010
Towards quantitative 3D imaging of the osteocyte lacuno-canalicular network Fulltext Access 11 Pages 2010
Cancellous bone allograft seeded with human mesenchymal stromal cells: a potential good manufacturing practice-grade tool for the regeneration of bone defects Fulltext Access 11 Pages 2010
Paracrine effect of canine allogenic umbilical cord blood-derived mesenchymal stromal cells mixed with beta-tricalcium phosphate on bone regeneration in ectopic implantations Fulltext Access 11 Pages 2010
A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells Fulltext Access 11 Pages 2010
Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures Fulltext Access 11 Pages 2010
Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe Fulltext Access 11 Pages 2010
Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study Fulltext Access 11 Pages 2010
Breast cancer in pregnancy: Recommendations of an international consensus meeting Fulltext Access 11 Pages 2010
Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells Fulltext Access 11 Pages 2010
IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: Evidence from a meta-analysis Fulltext Access 11 Pages 2010
Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy Fulltext Access 11 Pages 2010
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis Fulltext Access 11 Pages 2010
Interferon-λ induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents Fulltext Access 11 Pages 2010
The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells Fulltext Access 11 Pages 2010
Posttraumatic stress, depression and anxiety among adult long-term survivors of cancer in adolescence Fulltext Access 11 Pages 2010
Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39 Fulltext Access 11 Pages 2010
HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma Fulltext Access 11 Pages 2010
Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15 Fulltext Access 11 Pages 2010
Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006 Fulltext Access 11 Pages 2010
Current therapeutic approaches to fungal infections in immunocompromised hematological patients Fulltext Access 11 Pages 2010
On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer Fulltext Access 11 Pages 2010
Predictive biomarkers for personalised anti-cancer drug use: Discovery to clinical implementation Fulltext Access 11 Pages 2010
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours Fulltext Access 11 Pages 2010
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group Fulltext Access 11 Pages 2010
Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-β-dependent mechanism in diffuse-type gastric cancer cells Fulltext Access 11 Pages 2010
Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference Fulltext Access 12 Pages 2010
Poly(ADP-ribose) polymerase inhibitors in cancer treatment: A clinical perspective Fulltext Access 12 Pages 2010
Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in vivo bioluminescence imaging study Fulltext Access 12 Pages 2010
Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics Fulltext Access 12 Pages 2010
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Tr Fulltext Access 12 Pages 2010
Selective discussion and transparency in microarray research findings for cancer outcomes Fulltext Access 12 Pages 2010
Lifestyle changes and reduction of colon cancer incidence in Europe: A scenario study of physical activity promotion and weight reduction Fulltext Access 12 Pages 2010
Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma Fulltext Access 12 Pages 2010
EORTC elderly task force position paper: Approach to the older cancer patient Fulltext Access 12 Pages 2010
The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene Fulltext Access 12 Pages 2010
State of the epidemiological evidence on physical activity and cancer prevention Fulltext Access 12 Pages 2010
Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe Fulltext Access 12 Pages 2010
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction Fulltext Access 12 Pages 2010
Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redox-sensitive up-regulation of p73 and down-regulation of UHRF1 Fulltext Access 12 Pages 2010
Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease Fulltext Access 12 Pages 2010
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells Fulltext Access 12 Pages 2010
Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma Fulltext Access 12 Pages 2010
Clinical pharmacokinetics of the new oral camptothecin gimatecan: The inter-patient variability is related to α1-acid glycoprotein plasma levels Fulltext Access 12 Pages 2010